bf/NASDAQ:OCUL_icon.jpeg

NASDAQ:OCUL

Ocular Therapeutix

  • Stock

USD

Last Close

10.63

06/11 21:32

Market Cap

1.11B

Beta: 1.30

Volume Today

1.43M

Avg: 1.63M

PE Ratio

−5.67

PFCF: −7.52

    Description

    Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a de...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.6-0.5-0.4-0.3-0.2-0.12017-08-082019-08-072021-08-092023-08-072024-08-07

    Revenue (Estimate*)

    5M10M15M20M2017-08-082019-08-072021-08-092023-08-072024-08-07

    *Estimate based on analyst consensus